Longer time horizons and therapeutic area expertise make philanthropy venture capital an attractive option for biopharmaceutical companies developing new products. It can also de-risk funding rounds ...

Job rotations provide an opportunity for promising, high-potential employees to grow and learn new parts of the business.

Implementing AI in drug discovery offers significant potential for reducing operating costs, though the extent varies widely.

Using small molecule drugs to restore synapses in neurological diseases. Los Angeles-based Spinogenix, a privately held small molecule drug discovery and development company, is currently testing two ...